Study of head and neck squamous cell carcinoma transcriptome after proton therapy

QR Code

Study of head and neck squamous cell carcinoma transcriptome after proton therapy

Aim. To evaluate changes in the transcriptome of head and neck squamous cell carcinoma (HNSCC) tissue cells in patients after proton therapy.Materials and methods. Biopsy material obtained from 3 HNSCC patients before and after proton therapy at a total dose of 10 isoGy was homogenized, purified, an...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. D. Jumaniyazova, P. A. Vishnyakova, M. V. Chirkova, E. A. Karpulevich, I. Z. Eremina, K. B. Gordon, A. D. Kaprin, T. H. Fatkhudinov
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2024-04-01
Series:	Бюллетень сибирской медицины
Subjects:	head and neck squamous cell carcinoma transcriptome proton therapy signaling pathways
Online Access:	https://bulletin.ssmu.ru/jour/article/view/5523
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Methylation of the tumor associated genes in head and neck squamous cell carcinoma
by: S. V. Kurevlev, et al.
Published: (2023-03-01)

ASSESSMENT OF BLOOD SERUM PROTEOME IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: G. V. Kakurina, et al.
Published: (2016-02-01)

Proton beam therapy in repeat irradiation of recurrent head and neck tumors: analysis of short-term results
by: D. I. Smyk, et al.
Published: (2023-03-01)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
by: Muzaffar Shah-Khan, et al.
Published: (2013-03-01)

Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
by: A. M. Mudunov, et al.
Published: (2019-04-01)

Definitive treatment in squamous cell carcinoma of head and neck: A retrospective analysis of chemoradiotherapy in a university hospital setting
by: Hádila Silva Veras Sousa, et al.
Published: (2025-07-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)

Radiodosiomics Prediction of Treatment Failures Prior to Chemoradiotherapy in Head-and-Neck Squamous Cell Carcinoma
by: Hidemi Kamezawa, et al.
Published: (2025-06-01)

Molecular and genetic profile of head and neck squamous cell carcinoma
by: A. I. Stukan, et al.
Published: (2018-10-01)

HEAD AND NECK SQUAMOUS CELL CARCINOMA DEPENDING ON THE MORPHOLOGICAL CHARACTERISTICS OF THE PRIMARY TUMOR
by: V. A. Bychkov, et al.
Published: (2017-06-01)

NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
by: A. M. Mudunov, et al.
Published: (2017-06-01)

Pembrolizumab in treatment of head and neck squamous cell carcinoma: clinical cases and real-world practice
by: Yu. V. Alymov, et al.
Published: (2023-09-01)

EXPRESSION PROFILE OF MICRORNAS IN SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: Yu. A. Veryaskina, et al.
Published: (2016-02-01)

THE IMPORTANCE OF ACHIEVING LOCAL CONTROL IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CANCER
by: T. M. Sharabura, et al.
Published: (2017-06-01)

Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice
by: A. I. Stukan, et al.
Published: (2024-06-01)

EPIGENETIC REGULATION OF GENE EXPRESSION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: THERAPEUTIC PERSPECTIVES
by: R. B. Samsonov, et al.
Published: (2017-04-01)

Integrating metabolism gene clusters and tumor immune microenvironment in head and neck squamous cell carcinoma
by: Meina Lian, et al.
Published: (2025-06-01)

An update on head and neck squamous cell carcinoma in respect to classification and systemic therapy. Extended review
by: A. Mudunov, et al.
Published: (2018-04-01)

Factors associated with participation in a proton therapy clinical trial: a cross-sectional survey of Danish patients with head and neck cancer
by: Anne Wilhøft Kristensen, et al.
Published: (2025-07-01)

Efficacy of oral metronomic chemotherapy in the management of head and neck squamous cell carcinoma—a systematic review
by: Aardra Binithadas Segin Chandran, et al.
Published: (2025-07-01)

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
by: T. Braunschweig, et al.
Published: (2015-04-01)

Risk Factors and Diagnosis of Head and Neck Squamous Cell Carcinoma
by: Yussy Afriani Dewi, et al.
Published: (2024-12-01)

OPTIMAL TREATMENT STRATEGY FOR PATIENTS WITH PROGRESSIVE SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
by: L. V. Bolotina, et al.
Published: (2019-09-01)

Role of E-cadherin and β-catenin in head and neck squamous cell carcinoma
by: A. A. Petrova, et al.
Published: (2024-01-01)

Analysis of Selected Small Proline-Rich Proteins in Tissue Homogenates from Samples of Head and Neck Squamous Cell Carcinoma
by: Dariusz Nałęcz, et al.
Published: (2025-06-01)

Recurrent squamous cell carcinoma of head and neck: results of treatment in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine in 2012–2016
by: R. Yu. Karabut, et al.
Published: (2020-04-01)

Rational sequence of monoclonal antibodies in the treatment of non-resectable head and neck squamous cell carcinoma
by: L. V. Bolotina, et al.
Published: (2022-04-01)

Hyperfractionated radiotherapy with concurrent weekly paclitaxel and carboplatin for locally advanced unresectable head and neck squamous cell carcinoma
by: Perumal S, et al.
Published: (2025-06-01)

Radiation theraphy of head and neck cancer /
Published: (1989)

Mitochondrial DNA copy number is associated with risk of head and neck squamous cell carcinoma in Chinese population
by: Lihua Wang, et al.
Published: (2018-06-01)

Characteristics of inflammatory reactions in the tumor microenvironment of head and neck squamous cell carcinoma
by: V. A. Bychkov, et al.
Published: (2019-01-01)

Molecular features of head and neck squamous cell carcinoma
by: G. V. Kakurina, et al.
Published: (2018-09-01)

The results of immunotherapy in patients with recurrent and metastatic human papilloma virus positive head and neck squamous cell carcinoma
by: A. V. Ignatova, et al.
Published: (2024-06-01)

High cGAS-STING expression associates with improved efficacy of neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma
by: Miao Wang, et al.
Published: (2025-07-01)

From the history of development of departments of medical service for head and neck tumors
by: P. V. Svetitsky, et al.
Published: (2024-04-01)

<sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography in squamous cell carcinoma of the head and neck (literature review)
by: О. D. Ryzhova, et al.
Published: (2019-10-01)

Brachial Plexopathy in Head and Neck Cancer Potentially Related to LET-Dependent RBE
by: Abanob Hanna, et al.
Published: (2025-05-01)

Lymphoproliferative disorders affecting organs of the head and neck
by: F. Sh. Kamolova, et al.
Published: (2022-08-01)

Breaking the siege of hypoxia and lactate: carrier-free flexible dual-enzyme protein vesicle to ignite photodynamic-immune storm in head and neck squamous cell carcinoma
by: Yan Zhou, et al.
Published: (2025-08-01)

The Role of SARS1 in Head and Neck Squamous Cell Carcinoma and its Potential as a Diagnostic and Prognostic Biomarker
by: Qifeng Zhang, et al.
Published: (2025-10-01)